Regeneron and Sanofi Announce Positive DISCOVER Trial Results for Dupixent in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis in Communities of Color
8/6 00:40
Dupixent shows significant improvements in atopic dermatitis for patients with skin of color, addressing unique clinical challenges....